Evaluate Bioequivalence of Burotam (1/1 g/Vial)

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of cefoperazone sodium and sulbactam sodium combination (1/1 g/vial) after intravenous infusion of 1 g cefoperazone sodium and 1 g sulbactam sodium in healthy volunteers under fasting conditions
Epistemonikos ID: d03cd3a5bfada10048771011731e34db82e4d633
First added on: Oct 02, 2023